Access Oncology, Zentaris cancer deal

Access Oncology (New York, N.Y.) licensed from Zentaris (Frankfurt, Germany) exclusive development and marketing rights to cancer compound Perifosine in the U.S., Canada and Mexico. Zentaris will rece...